Skip to content

SCHEDULE 13D/AAccepted Oct 29, 6:04 PM ET

X4 Pharmaceuticals, Inc SCHEDULE 13D/A

Growth Equity Opportunities 18 VGE, LLC

Accepted (ET)

6:04 PM

Oct 29, 2025

Filed

Oct 29, 2025

Documents

3

Size

92.2 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.